NCT02262598View on ClinicalTrials.gov

Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Telmisartan

DRUG

Hydrochlorthiazide (HCTZ)

DRUG

Telmisartan/HCTZ fixed dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02262598 - Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter